DE706395T1 - Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade - Google Patents

Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade

Info

Publication number
DE706395T1
DE706395T1 DE0706395T DE94919912T DE706395T1 DE 706395 T1 DE706395 T1 DE 706395T1 DE 0706395 T DE0706395 T DE 0706395T DE 94919912 T DE94919912 T DE 94919912T DE 706395 T1 DE706395 T1 DE 706395T1
Authority
DE
Germany
Prior art keywords
ropivacaine
block
motoric
analgetic
music
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0706395T
Other languages
German (de)
English (en)
Inventor
Arne Torsten Eek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE706395(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra AB filed Critical Astra AB
Publication of DE706395T1 publication Critical patent/DE706395T1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Air Conditioning Control Device (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Particle Accelerators (AREA)
  • Medicinal Preparation (AREA)
DE0706395T 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade Pending DE706395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use
PCT/SE1994/000496 WO1995000148A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Publications (1)

Publication Number Publication Date
DE706395T1 true DE706395T1 (de) 1997-09-04

Family

ID=20390432

Family Applications (2)

Application Number Title Priority Date Filing Date
DE0706395T Pending DE706395T1 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikmus mit minimaler motorischer blockade
DE69430427T Expired - Lifetime DE69430427T2 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69430427T Expired - Lifetime DE69430427T2 (de) 1993-06-28 1994-05-26 Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade

Country Status (32)

Country Link
US (2) US5670524A (enExample)
EP (1) EP0706395B1 (enExample)
JP (1) JP3725541B2 (enExample)
CN (1) CN1074918C (enExample)
AT (1) ATE216237T1 (enExample)
BR (1) BR9406865A (enExample)
CA (1) CA2165446C (enExample)
CZ (1) CZ283300B6 (enExample)
DE (2) DE706395T1 (enExample)
DK (1) DK0706395T3 (enExample)
EE (1) EE03205B1 (enExample)
ES (1) ES2099048T3 (enExample)
FI (1) FI956269L (enExample)
GR (1) GR970300013T1 (enExample)
HU (1) HU218949B (enExample)
IL (1) IL110006A (enExample)
IS (1) IS4174A (enExample)
LT (1) LT3449B (enExample)
LV (1) LV12918B (enExample)
MY (1) MY119360A (enExample)
NO (1) NO955313D0 (enExample)
NZ (1) NZ268110A (enExample)
PH (1) PH31258A (enExample)
PL (1) PL175518B1 (enExample)
PT (1) PT706395E (enExample)
RU (1) RU2152215C1 (enExample)
SA (1) SA94150010B1 (enExample)
SE (1) SE9302218D0 (enExample)
SG (1) SG49078A1 (enExample)
SK (1) SK280111B6 (enExample)
TW (1) TW285640B (enExample)
WO (1) WO1995000148A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CA2294950C (en) * 1997-07-21 2009-04-07 Darwin Discovery Limited Levobupivacaine and its use
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009061497A1 (en) 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
AU2013257727B2 (en) * 2012-05-10 2016-04-28 Cellixbio Private Limited Compositions and methods for the treatment of local pain
CN104427977B (zh) * 2012-05-10 2018-02-02 佩因拉佛姆有限公司 局部麻醉剂的储库制剂及其制备方法
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
JPH09500620A (ja) 1997-01-21
CN1074918C (zh) 2001-11-21
EE03205B1 (et) 1999-08-16
GR970300013T1 (en) 1997-05-31
WO1995000148A1 (en) 1995-01-05
CA2165446A1 (en) 1995-01-05
EP0706395A1 (en) 1996-04-17
ES2099048T1 (es) 1997-05-16
NZ268110A (en) 1999-06-29
DE69430427T2 (de) 2002-11-14
PT706395E (pt) 2002-09-30
HU9503692D0 (en) 1996-02-28
FI956269A7 (fi) 1995-12-27
HU218949B (hu) 2001-01-29
LV12918B (en) 2003-03-20
US5834489A (en) 1998-11-10
NO955313L (no) 1995-12-27
CZ283300B6 (cs) 1998-02-18
ATE216237T1 (de) 2002-05-15
FI956269A0 (fi) 1995-12-27
HK1010344A1 (en) 1999-06-17
SK280111B6 (sk) 1999-08-06
PH31258A (en) 1998-06-18
CZ336495A3 (en) 1996-06-12
ES2099048T3 (es) 2002-11-16
IL110006A0 (en) 1994-11-11
BR9406865A (pt) 1996-03-26
IL110006A (en) 1999-01-26
LT3449B (en) 1995-10-25
CA2165446C (en) 2005-07-05
SA94150010B1 (ar) 2006-04-04
RU2152215C1 (ru) 2000-07-10
AU692161B2 (en) 1998-06-04
US5670524A (en) 1997-09-23
SK164695A3 (en) 1996-07-03
TW285640B (enExample) 1996-09-11
LTIP1958A (en) 1995-01-31
IS4174A (is) 1994-12-29
MY119360A (en) 2005-05-31
CN1126435A (zh) 1996-07-10
PL312198A1 (en) 1996-04-01
EP0706395B1 (en) 2002-04-17
AU7086694A (en) 1995-01-17
DE69430427D1 (de) 2002-05-23
PL175518B1 (pl) 1999-01-29
NO955313D0 (no) 1995-12-27
JP3725541B2 (ja) 2005-12-14
FI956269L (fi) 1995-12-27
SG49078A1 (en) 1998-05-18
DK0706395T3 (da) 2002-07-22
HUT75115A (en) 1997-04-28
SE9302218D0 (sv) 1993-06-28

Similar Documents

Publication Publication Date Title
AU609664B1 (en) A method of treating premature ejaculation using sertraline
KR960702318A (ko) 근육 질병 및 장애의 치료방법
DE869796T1 (de) Zusammensetzung von glibenclamid und metformine zur behandlung von diabetes mellitis typ ii
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
DE68912459D1 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
DE69506686D1 (de) Verwendung von bis (amidinobenzidazolen) zur herstellung eines medikamentes für die hemmung der retroviral integrase
DE69330272D1 (de) 4-imidomethyl-1-[2'-phenyl-2-oxoethyl]-piperidine als serotonin-5ht2-antagonisten, ihre herstellung und therapeutische anwendung
DE69612510D1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
DE69424317T2 (de) Hemmung der migration von glatten mushelzellen durch (r)-amlodipin
MXPA04004826A (es) Antagonista del receptor de quimioquinas y metodos para su uso.
DE69430427D1 (de) Verwendung von ropivacaine zur herstellung eines analgetikums mit minimaler motorischer blockade
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
HU905683D0 (en) The treatment of drug dependence by using sertraline
DE69424415D1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE238780T1 (de) Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
KR900007806A (ko) 트랜스-4-아미노(알킬)-1-피리딜카르바모일 시클로헥산 화합물 및 이의 약학적 용도
ATE111732T1 (de) Verwendung von 1,4-dihydropyridinen zur herstellung eines arzneimittels, zur behandlung von neuropathien, die durch diabetes mellitus verursacht sind.
RU98113711A (ru) Новый способ лечения резистентности к инсулину